Myasthenia gravis (MG) is an autoimmune neuromuscular disorder characterized by muscle weakness and fatigue. It results from the production of autoantibodies that target and disrupt the function of acetylcholine receptors at the neuromuscular junction, impairing nerve-to-muscle signal transmission. Classification Medications used in the treatment of myasthenia gravis can be categorized …